PNT's chart is flat-lining, but the news is pure fireworks! 🎇 Eli Lilly's buyout is the only story, making technicals irrelevant. The stock is locked in a holding pattern until that tender closes. It's a binary play on the deal going through. For traders? No action here. For deal arbs? That ship has mostly sailed. My call: HOLD if you own it, but don't jump in now. #MergerArbitrage

Whoa, the entire PNT sector is buzzing like a cesium atom! 🧪 While the chart data is MIA, the news flow is pure rocket fuel. Defense contracts, new tech launches, and Eli Lilly's relentless pursuit of POINT Biopharma signal massive institutional belief in this space. This isn't just one deal; it's an entire ecosystem waking up. The trend vibe is aggressively bullish on the theme. Strong BUY signal on the sector narrative. #TimingIsEverything